Drug Research: Incentives for New Uses of Old Medicines
This bill is currently in the early stages of the legislative process. It has been sent to two House committees for review and is waiting for further action. It is considered active as it moves through these initial committee assignments.
While the bill has bipartisan support, most bills introduced in the House never make it to a final vote, especially those that change how much money the government collects from drug companies.
Govbase has not yet run an impact analysis on this legislation.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes have been recorded for this legislation yet.
No related news coverage found for this legislation yet.
Document Type
Congressional Bill
Official Title
Old Drugs, New Cures Act
Analysis generated by AI. Always verify with official sources.